We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · January 21, 2015

Macitentan Reduces Hospitalizations in Patients With Pulmonary Arterial Hypertension

JACC: Heart Failure


Additional Info

JACC: Heart Failure
Effect of Macitentan on Hospitalizations: Results From the SERAPHIN Trial
JACC Heart Fail 2015 Jan 01;3(1)1-8, RN Channick, M Delcroix, HA Ghofrani, E Hunsche, P Jansa, FO Le Brun, S Mehta, T Pulido, LJ Rubin, BK Sastry, G Simonneau, O Sitbon, R Souza, A Torbicki, N Galiè

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading